• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER PFO OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Lot Number 7081510
Device Problem Biocompatibility (2886)
Patient Problems Skin Erosion (2075); Pericardial Effusion (3271)
Event Type  Injury  
Manufacturer Narrative
Further information regarding this event has been requested.Investigation results will be provided in a subsequent submission.
 
Event Description
On (b)(6) 2020 the patient underwent an implant of a 35 mm amplatzer pfo occluder.3 months post procedure, the patient developed a pericardial effusion and was admitted to the hospital.The patient underwent a pericardiocentesis for treatment.The patient has been referred to cardiac surgery to remove the device today, (b)(6) 2020.A tee revealed suspected aortic erosion from the right disc of the device.The physicians suspects the device may have been too large for the patient.The patient is stable.
 
Manufacturer Narrative
Additional information g4, h2, h3, h6, h10.An event of erosion if the device 3 months after implant, causing a pericardial effusion was reported.A more comprehensive assessment could not be performed as the device was not returned for analysis.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER PFO OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key9981609
MDR Text Key188902453
Report Number2135147-2020-00164
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
P120021
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 06/15/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot Number7081510
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Initial Date Manufacturer Received 04/16/2020
Initial Date FDA Received04/21/2020
Supplement Dates Manufacturer Received05/28/2020
Supplement Dates FDA Received06/15/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Life Threatening; Required Intervention;
-
-